$INFU
InfuSystem Holdings, Inc

2014 Q1 Form 10-Q Financial Statement

#000119312514181070 Filed on May 05, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $17.24M $14.70M
YoY Change 17.28% 2.45%
Cost Of Revenue $2.890M $2.579M
YoY Change 12.06% -34.04%
Gross Profit $12.08M $10.42M
YoY Change 15.86% -0.16%
Gross Profit Margin 70.04% 70.9%
Selling, General & Admin $7.564M $7.439M
YoY Change 1.68% -27.57%
% of Gross Profit 62.64% 71.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $100.0K $100.0K
YoY Change 0.0% -85.29%
% of Gross Profit 0.83% 0.96%
Operating Expenses $10.30M $9.771M
YoY Change 5.41% -10.77%
Operating Profit $1.776M $652.0K
YoY Change 172.39% -227.84%
Interest Expense $827.0K $874.0K
YoY Change -5.38% -245.67%
% of Operating Profit 46.57% 134.05%
Other Income/Expense, Net -$844.0K -$562.0K
YoY Change 50.18%
Pretax Income $932.0K $90.00K
YoY Change 935.56% -108.11%
Income Tax $349.0K $39.00K
% Of Pretax Income 37.45% 43.33%
Net Earnings $583.0K $51.00K
YoY Change 1043.14% -105.54%
Net Earnings / Revenue 3.38% 0.35%
Basic Earnings Per Share $0.03 $0.00
Diluted Earnings Per Share $0.03 $0.00
COMMON SHARES
Basic Shares Outstanding 21.97M shares 21.80M shares
Diluted Shares Outstanding 22.46M shares 22.24M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $500.0K $500.0K
YoY Change 0.0%
Cash & Equivalents $496.0K $472.0K
Short-Term Investments
Other Short-Term Assets $714.0K $2.800M
YoY Change -74.5% 75.0%
Inventory $1.398M $1.400M
Prepaid Expenses
Receivables $12.10M $9.600M
Other Receivables $0.00 $0.00
Total Short-Term Assets $17.00M $14.20M
YoY Change 19.74% 2.9%
LONG-TERM ASSETS
Property, Plant & Equipment $915.0K $16.70M
YoY Change -94.52% 12.08%
Goodwill
YoY Change
Intangibles $24.08M
YoY Change
Long-Term Investments
YoY Change
Other Assets $238.0K $20.50M
YoY Change -98.84% 5.67%
Total Long-Term Assets $61.25M $62.00M
YoY Change -1.21% 0.32%
TOTAL ASSETS
Total Short-Term Assets $17.00M $14.20M
Total Long-Term Assets $61.25M $62.00M
Total Assets $78.25M $76.20M
YoY Change 2.69% 0.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.153M $3.100M
YoY Change 66.23% -3.13%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.305M $3.900M
YoY Change 36.03% -38.1%
Total Short-Term Liabilities $12.94M $11.10M
YoY Change 16.55% -8.26%
LONG-TERM LIABILITIES
Long-Term Debt $21.86M $24.60M
YoY Change -11.12% 4.68%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $21.86M $24.60M
YoY Change -11.12% 2.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.94M $11.10M
Total Long-Term Liabilities $21.86M $24.60M
Total Liabilities $34.80M $35.70M
YoY Change -2.52% -1.11%
SHAREHOLDERS EQUITY
Retained Earnings -$46.48M
YoY Change
Common Stock $2.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $43.45M $40.50M
YoY Change
Total Liabilities & Shareholders Equity $78.25M $76.20M
YoY Change 2.69% 0.79%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income $583.0K $51.00K
YoY Change 1043.14% -105.54%
Depreciation, Depletion And Amortization $100.0K $100.0K
YoY Change 0.0% -85.29%
Cash From Operating Activities -$640.0K $1.630M
YoY Change -139.26% -8250.0%
INVESTING ACTIVITIES
Capital Expenditures $1.127M -$1.780M
YoY Change -163.31% -15.24%
Acquisitions
YoY Change
Other Investing Activities $1.250M $1.090M
YoY Change 14.68% 17.2%
Cash From Investing Activities $130.0K -$680.0K
YoY Change -119.12% -41.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -130.0K -2.800M
YoY Change -95.36% -817.95%
NET CHANGE
Cash From Operating Activities -640.0K 1.630M
Cash From Investing Activities 130.0K -680.0K
Cash From Financing Activities -130.0K -2.800M
Net Change In Cash -640.0K -1.850M
YoY Change -65.41% 131.25%
FREE CASH FLOW
Cash From Operating Activities -$640.0K $1.630M
Capital Expenditures $1.127M -$1.780M
Free Cash Flow -$1.767M $3.410M
YoY Change -151.82% 63.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
472000
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21998268 shares
CY2014Q1 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0950 pure
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22195958 shares
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22375438 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
19113000
CY2014Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21864000
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89925000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5153000
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
12937000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
43449000
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5875000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46478000
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
2000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
78250000
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3653000
CY2014Q1 us-gaap Long Term Debt
LongTermDebt
27169000
CY2014Q1 us-gaap Liabilities
Liabilities
34801000
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
4392000
CY2014Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2479000
CY2014Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
11000
CY2014Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
5305000
CY2014Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
39146000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
11260000
CY2014Q1 us-gaap Assets Current
AssetsCurrent
17003000
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24075000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
238000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2191000
CY2014Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
15998000
CY2014Q1 us-gaap Assets
Assets
78250000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
496000
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12099000
CY2014Q1 us-gaap Inventory Net
InventoryNet
1398000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2321000
CY2014Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1661000
CY2014Q1 us-gaap Other Assets Current
OtherAssetsCurrent
714000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2235000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2201000
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2296000
CY2014Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1867000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
915000
CY2014Q1 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
92000
CY2014Q1 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
15071000
CY2014Q1 infu Medical Equipment Net
MedicalEquipmentNet
18360000
CY2014Q1 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
23047000
CY2014Q1 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
2955000
CY2014Q1 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
15405000
CY2014Q1 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
38544000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2326000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21960351 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22158041 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21609000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89783000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4736000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13041000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
42723000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4774000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47062000
CY2013Q4 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
22727000
CY2013Q4 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
3664000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
217000
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
16300000
CY2013Q4 us-gaap Assets
Assets
77373000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1138000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10697000
CY2013Q4 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
14438000
CY2013Q4 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
37252000
CY2013Q4 us-gaap Inventory Net
InventoryNet
1234000
CY2013Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1817000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
518000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2296000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
872000
CY2013Q4 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
87000
CY2013Q4 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
14438000
CY2013Q4 infu Medical Equipment Net
MedicalEquipmentNet
18102000
CY2013 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22238160 shares
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.434 pure
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1632000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77373000
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
26727000
CY2013Q4 us-gaap Liabilities
Liabilities
34650000
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3187000
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5118000
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
38620000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
15883000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24182000
CY2013Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
435645 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21802515 shares
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
51000
CY2013Q1 us-gaap Gross Profit
GrossProfit
10423000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
90000
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1256000
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
312000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
652000
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-562000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
51000
CY2013Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
2802000
CY2013Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
13445000
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
14701000
CY2013Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1777000
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5031000
CY2013Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2579000
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2802000
CY2013Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1093000
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1660000
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1854000
CY2013Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2408000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-684000
CY2013Q1 us-gaap Interest Expense
InterestExpense
874000
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
672000
CY2013Q1 us-gaap Depreciation
Depreciation
100000
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
9771000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39000
CY2013Q1 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1699000
CY2013Q1 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1200000
CY2014Q1 dei Trading Symbol
TradingSymbol
INFU
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
InfuSystem Holdings, Inc
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001337013
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22456143 shares
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2014Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2016-11-30
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.374 pure
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-636000
CY2014Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
483404 shares
CY2014Q1 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P7Y
CY2014Q1 us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
LIBOR plus 7.25% (with a LIBOR floor of 2.0%) or the Wells Fargo prime rate plus 6.25% (with a prime rate floor of 3.0%)
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21972739 shares
CY2014Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1127000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
932000
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2392000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1776000
CY2014Q1 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
14263000
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4909000
CY2014Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2890000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-131000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
583000
CY2014Q1 us-gaap Gross Profit
GrossProfit
12076000
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-844000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
583000
CY2014Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
14394000
CY2014Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
14850000
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
17242000
CY2014Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1252000
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2107000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-642000
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2655000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
125000
CY2014Q1 us-gaap Interest Expense
InterestExpense
827000
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
629000
CY2014Q1 us-gaap Depreciation
Depreciation
100000
CY2014Q1 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
700000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
10300000
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
349000
CY2014Q1 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
2276000
CY2014Q1 infu Effect Of Change In Accounting Estimate On Estimated Useful Life Of Assets
EffectOfChangeInAccountingEstimateOnEstimatedUsefulLifeOfAssets
-500000
CY2014Q1 infu Effect Of Change In Accounting Estimate On Estimated Useful Life Of Assets Increase Decrease Net Income
EffectOfChangeInAccountingEstimateOnEstimatedUsefulLifeOfAssetsIncreaseDecreaseNetIncome
-300000
CY2014Q1 infu Effect Of Change In Accounting Estimate On Estimated Useful Life Of Assets Earnings Per Share Basic And Diluted
EffectOfChangeInAccountingEstimateOnEstimatedUsefulLifeOfAssetsEarningsPerShareBasicAndDiluted
0

Files In Submission

Name View Source Status
0001193125-14-181070-index-headers.html Edgar Link pending
0001193125-14-181070-index.html Edgar Link pending
0001193125-14-181070.txt Edgar Link pending
0001193125-14-181070-xbrl.zip Edgar Link pending
d715859d10q.htm Edgar Link pending
d715859dex101.htm Edgar Link pending
d715859dex311.htm Edgar Link pending
d715859dex312.htm Edgar Link pending
d715859dex321.htm Edgar Link pending
d715859dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
infu-20140331.xml Edgar Link completed
infu-20140331.xsd Edgar Link pending
infu-20140331_cal.xml Edgar Link unprocessable
infu-20140331_def.xml Edgar Link unprocessable
infu-20140331_lab.xml Edgar Link unprocessable
infu-20140331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending